Jeff Calcagno

Jeff graduated Phi Beta Kappa in Biology from Harvard College and earned an MD from Harvard Medical School, where he was a Rotary International Ambassadorial Scholar. He completed his medical-psychiatric internship and psychiatry residency at UCLA's Neuropsychiatric Institute and served as program chief resident. Afterwards, he was awarded and completed a clinical neuropharmacology fellowship, focusing on the care of treatment-refractory patients. He is conversational in six languages.

Jeff is a senior healthcare business executive and investor focused on fostering innovation in healthcare and technology. Based in Johnson & Johnson's California Innovation Center, which he helped to establish, he is responsible for identifying new technologies to better treat patients for Johnson & Johnson (J&J), the world's largest healthcare company. Jeff joined the Johnson & Johnson Family of Companies in February 2011 and helped to establish the California Innovation Center. He also worked for 18 months making and managing venture investments for Johnson & Johnson. A licensed physician, he has over two decades of diversified healthcare and business experience: as a senior operating executive, business development professional, venture investor, entrepreneur, and clinician. 

​

Jeff began his business career as a management consultant at McKinsey & Company. He later served as a healthcare research analyst at JP Morgan Hambrecht & Quist. As an entrepreneur, he ran corporate development and operations for WIDCOMM, a technology company acquired by Broadcom, and served as CFO & CBO for Vela Pharmaceuticals, a venture-backed drug development company. From 2006 to 2010 he was a Principal and Kauffman Fellow at Scale Venture Partners, a venture fund with over $1 billion under management.

A member of Class 11, Jeff served his fellowship at Scale Venture Partners under the mentorship of Lou Bock.